Thalidomide
Currently it is approved by the U.S. Food and Drug Administration (FDA) for use in treating a skin disease associated with leprosy.
Please make a donation to the Aplastic Anemia and MDS International Foundation.
Donate Today
Currently it is approved by the U.S. Food and Drug Administration (FDA) for use in treating a skin disease associated with leprosy.
Mycophenolate mofetil Mycophenolate mofetil: Mycophenolate mofetil is approved by the U.S.
Lenalidomide Lenalidomide: Lenalidomide is a capsule that is taken by mouth.
The U.S. Food and Drug Administration (FDA) approved fludarabine fludarabine: The U.S. Food and Drug Administration (FDA) approved fludarabine for treating chronic lymphocytic leukemia (CCL).
It is known as a hematopoietic growth factor growth factor: A substance made by the body that stimulates the bone marrow to produce blood cells.
Epoetin alfa Epoetin alfa: Epoetin alfa can help improve red blood cell counts in bone marrow failure disease patients whose natural erythropoietin levels are low.
Eculizumab Eculizumab: Eculizumab (Soliris ®) is given as an IV into a vein at the doctor’s office or at a special center. The procedure usually takes about 35 minutes.
Deferiprone Deferiprone: Deferiprone is in a class of medications called iron chelators.
It comes in a tablet form which is dissolved in juice or water and taken by mouth. Iron build-up can occur in patients who get a lot of red blood cell red blood cell: The most
It works by reducing the amount of methylation in the body. Methylation is a process that acts like a switch to turn off or “silence” genes in certain cells. When these genes (called tumor suppressor genes) are turned off, MDS cells and cancer cells can grow freely.